Annual recurring revenue quote has dropped from last quarterly of $5.73m ARR to $4.3m ARR in this quarterly. (Based on conservative numbers) Wonder why they have changed their forecasts?
@fattchoi Your 2025 expectation looks in line with their schedule in this presentation. Not much happening this year so wonder why it is expected to be transformational for PainChek.
Ann: Quarterly Investor Update Presentation, page-2
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
0.001(3.45%) |
Mkt cap ! $49.07M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.1¢ | 2.9¢ | $25.61K | 868.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 912873 | 2.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.0¢ | 200000 | 1 |
View Market Depth
| Last trade - 15.31pm 25/04/2024 (20 minute delay) ? |
|
|||||
|
Last
3.0¢ |
Change
0.001 ( 1.69 %) |
||||
| Open | High | Low | Volume | ||
| 2.9¢ | 3.1¢ | 2.9¢ | 446273 | ||
| Last updated 15.31pm 25/04/2024 ? | |||||
| PCK (ASX) Chart |